DTLVX
Price
$21.21
Change
-$0.60 (-2.75%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

DTLVX vs RMFCX

Header iconDTLVX vs RMFCX Comparison
Open Charts DTLVX vs RMFCXBanner chart's image
Wilshire Large Company Value Invmt
Price$21.21
Change-$0.60 (-2.75%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
DTLVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DTLVX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTLVX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. DTLVX (166M). RMFCX pays higher dividends than DTLVX: RMFCX (1.69) vs DTLVX (0.51). DTLVX was incepted earlier than RMFCX: DTLVX (32 years) vs RMFCX (23 years). DTLVX is a more actively managed with annual turnover of: 50.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than DTLVX: RMFCX (250) vs DTLVX (250000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. DTLVX (10.41). RMFCX return over 5 years is better than : 40.39 vs. DTLVX (12.34).
DTLVXRMFCXDTLVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years23 years-
Gain YTD9.34411.42382%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets166M98.7B0%
Annual Yield % from dividends0.511.6930%
Returns for 1 year10.4112.6382%
Returns for 3 years2.6314.1619%
Returns for 5 years12.3440.3931%
Returns for 10 years12.8361.8421%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc